Fig. 3From: Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVFDeterministic sensitivity analysis – Tornado chart. ICER Incremental Cost-Effectiveness RatioBack to article page